FDA Increases Antiangiogenic Treatment Options for Kidney Cancer
Late last week, the U.S. Food and Drug Administration (FDA) added another antiangiogenic therapeutic to the armamentarium for oncologists...
Category: Research
Late last week, the U.S. Food and Drug Administration (FDA) added another antiangiogenic therapeutic to the armamentarium for oncologists...
We observe May as National Cancer Research Month to celebrate the tremendous advances that have been made in our...
The U.S. Food and Drug Administration (FDA) recently approved the use of molecularly targeted therapeutic afatinib (Gilotrif) for treating...
On April 19, Sven Bilke, PhD, staff scientist in the Genetics Branch of the National Cancer Institute, discussed his...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the antiangiogenic...
In a study presented at the AACR Annual Meeting 2016 on April 19, researchers engineered an organic bispecific adaptor...
Earlier this month, the U.S. Food and Drug Administration (FDA) approved a new colorectal cancer screening test, the ‘System,...
Data presented at the AACR Annual Meeting 2016, on April 19, showed that a microdevice about the size of...
Immunotherapy was one of the hottest topics at last year’s AACR Annual Meeting, and this year the trend is...
Last week, the U.S. Food and Drug Administration (FDA) added another therapeutic to the armamentarium for hematologist-oncologists when it...